Dr. Marcos Ignacio Restrepo, M.D., M.SC. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 7400 Merton Minter Blvd, San Antionio, TX 78229 Phone: 210-617-5300 Fax: 210-567-4423 |
News Archive
A new treatment under investigation for multiple sclerosis (MS) is safe and tolerable in phase I clinical trials, according to a study published August 27, 2014, in Neurology Neuroimmunology & Neuroinflammation, a new online-only, freely accessible, specialty medical journal.
Chronic myeloid leukemia (CML) is a particular form of leukemia or cancer of the bone marrow, which can be treated with targeted imatinib. However, in some cases this medicine has no effect. Researchers at the VIB Vesalius Research Centre, K.U. Leuven, under the direction of Peter Carmeliet, have investigated the role of placental growth factor (PlGF) in mice with CML.
In a study that included more than 800 women who had undergone surgery for breast cancer, the majority reported some level of pain 12 months after surgery, and factors associated with pain included chronic preoperative pain, chemotherapy, preoperative depression and pain in the area to be operated, according to a study appearing in the January 1 issue of JAMA.
OXINIUM Oxidized Zirconium, the patented advanced bearing material from Smith & Nephew Orthopaedics Division, has been awarded a C1 premium reimbursement classification in Japan for use in hip replacement surgery.
› Verified 1 days ago